logo

For the Inventor, By the Inventor

San Mateo, CA, United States of America

Marian N Marra

This inventor holds 11 USPTO granted patents, plus 1 CIPO patent. Top assignees: Incyte Pharmaceuticals, Inc., Invitron Limited. Active years: 1991-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Marian N Marra. Retrieved from https://idiyas.com/inventor/marian-n-marra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.3

ph-index = 7

Forward Citations = 355(Granted Patents)


Location History:

  • San Mateo, CA (US) (1991 - 2000)
  • Redwood City, CA (US) (2001)

Company Filing History:

goldMedal10 out of 576 
 
Incyte Pharmaceuticals, Inc.
 patents
silverMedal1 out of 4 
 
Invitron Limited
 patents

Years Active: 1991-2001

Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents
1. 6265187 - Recombinant endotoxin-neutralizing proteins (2001-07-24),
2. 6093801 - Recombinant analogs of bactericidal/permeability increasing protein (2000-07-25),
3. 5770694 - Genetically engineered BPI variant proteins (1998-06-23),
4. 5532216 - Neutralization of non-lipopolysaccharide compounds by (1996-07-02),
5. 5334584 - Recombinant, non-glycosylated bpi protein and uses thereof (1994-08-02),
6. 5308834 - Treatment of endotoxin-associated shock and prevention thereof using a (1994-05-03),
7. 5234912 - Pharmaceutical compositions comprising recombinant BPI proteins and a (1993-08-10),
8. 5210027 - DNA encoding novel antimicrobial polypeptide and methods for obtaining (1993-05-11),
9. 5171739 - Treatment of endotoxin-associated shock and preventation thereof using a (1992-12-15),
10. 5089274 - Use of bactericidal/permeability increasing protein or biologically (1992-02-18),
11. 5032574 - Novel antimicrobial peptide (1991-07-16),

Title: Marian N Marra: Innovator in Endotoxin-Neutralizing Proteins

Introduction

Marian N Marra is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of recombinant endotoxin-neutralizing proteins. With a total of 11 patents to her name, her work has had a substantial impact on therapeutic and diagnostic methods.

Latest Patents

One of her latest patents focuses on recombinant endotoxin-neutralizing polypeptides (RENP). This invention features a RENP characterized by an amino acid sequence that facilitates selective and specific binding to lipopolysaccharide. Once bound, the RENP provides endotoxin-neutralizing activity. The invention also includes recombinant analogs of bactericidal/permeability increasing protein (BPI), which exhibit endotoxin-neutralizing activity without bacterial activity. These innovations can be utilized in pharmaceutical compositions for therapeutic and prophylactic regimens, as well as in various diagnostic methods.

Career Highlights

Marian has worked with notable companies such as Incyte Pharmaceuticals, Inc. and Invitron Limited. Her expertise in the field has allowed her to develop groundbreaking technologies that address critical health challenges.

Collaborations

Throughout her career, Marian has collaborated with esteemed colleagues, including Randal W Scott and Craig G Wilde. These partnerships have further enhanced her research and development efforts.

Conclusion

Marian N Marra's contributions to the field of biotechnology, particularly in endotoxin-neutralizing proteins, highlight her innovative spirit and dedication to improving health outcomes. Her work continues to influence therapeutic and diagnostic advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…